b+pharma Belgium
0474.817.869 · rovalta.com · 22/09/2026
ACTIVE
b+pharma Belgium
Financial year 2025 · closed on 31/12/2025
Net result
213,5 k €
+5.1% YoY
Gross margin
287 k €
+1.3% YoY
Equity
2,2 M €
+11.0% YoY
Workforce
0,0 ETP
Overview
What does b+pharma Belgium do?
b+pharma Belgium is a Public limited company incorporated in 2001. Its main activity is: Agents specialised in the sale of other particular products. Its registered office is in Gent.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0474.817.869
Incorporation
22/05/2001
Legal form
Public limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
9051 Gent · FlandreSee on map
Contributed capital
2 350 000,00 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Activities (NACE)
46180Agents specialised in the sale of other particular products· main46180Agents specialised in the sale of other particular products46190Agents involved in the sale of a variety of goods46190Agents involved in the sale of a variety of goods46382Wholesale of other food, including fish, crustaceans and molluscs46383Wholesale of other food, including fish, crustaceans and molluscs+4
Joint committees (3)
- 118
- 220
- 2200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||
| Gross margin | 287 k € | +1.3% | 283,3 k € | +21.9% | 232,4 k € | -71.5% | 816,9 k € | +23.2% | 663,3 k € | +47.3% | 450,3 k € | -53.5% | 967,7 k € | -28.9% | 1,4 M € | -18.2% | 1,7 M € | – | 1,2 M € | +166% | 466,2 k € | -25.0% | 621,6 k € | +413% | -198,6 k € | -133% | 593,3 k € | +345% | 133,4 k € | ||
| EBITDA | 284,9 k € | +1.0% | 282,1 k € | +32.0% | 213,7 k € | -58.4% | 514,2 k € | +106% | 249,3 k € | +503% | -61,8 k € | -115% | 400,8 k € | -19.2% | 496,2 k € | +45.3% | 341,5 k € | -14.3% | 398,6 k € | +24.0% | 321,6 k € | +214% | -282,3 k € | -150% | -113,1 k € | +85.0% | -752 k € | -889% | 95,3 k € | +131% | -308,9 k € |
| Operating result | 283,2 k € | +7.5% | 263,5 k € | +2.0% | 258,3 k € | -42.8% | 451,2 k € | +165% | 170,2 k € | +199% | -171,5 k € | -171% | 242,2 k € | -44.6% | 437,4 k € | +116% | 202,2 k € | +51.0% | 133,9 k € | -15.2% | 158 k € | +135% | -448,9 k € | -65.0% | -272 k € | +66.8% | -820,4 k € | -1893% | 45,7 k € | +113% | -353,4 k € |
| Net result | 213,5 k € | +5.1% | 203,2 k € | +4.5% | 194,5 k € | -53.4% | 416,9 k € | +156% | 162,8 k € | +192% | -177 k € | -174% | 239,4 k € | -45.5% | 439,3 k € | +140% | 182,9 k € | +824% | -25,3 k € | -197% | 25,9 k € | +105% | -549,5 k € | -56.6% | -351 k € | +59.8% | -872,7 k € | -253057% | 345 € | +100% | -390 k € |
| Balance sheet | |||||||||||||||||||||||||||||||
| Equity | 2,2 M € | +11.0% | 1,9 M € | +11.7% | 1,7 M € | +12.6% | 1,5 M € | +37.0% | 1,1 M € | +36.4% | 825,9 k € | -17.6% | 1 M € | +31.3% | 763,6 k € | +136% | 324,2 k € | +129% | 141,3 k € | -15.2% | 166,6 k € | +18.4% | 140,7 k € | +55.9% | 90,2 k € | +36.3% | 66,2 k € | -88.3% | 563,9 k € | +79.8% | 313,6 k € |
| Total assets | 2,4 M € | +12.2% | 2,1 M € | +9.2% | 2 M € | -5.5% | 2,1 M € | +32.8% | 1,6 M € | -17.3% | 1,9 M € | -10.5% | 2,1 M € | -30.5% | 3 M € | +10.2% | 2,7 M € | -24.9% | 3,7 M € | +7.2% | 3,4 M € | +7.4% | 3,2 M € | +1.7% | 3,1 M € | +42.6% | 2,2 M € | -13.8% | 2,5 M € | +58.9% | 1,6 M € |
| Cash | – | – | 0 € | -100% | 354,3 k € | -0.4% | 355,8 k € | +41.1% | 252,1 k € | -36.1% | 394,9 k € | +100.0% | 197,5 k € | -10.9% | 221,7 k € | -66.2% | 655,5 k € | +91.9% | 341,6 k € | +69.7% | 201,3 k € | +27.1% | 158,4 k € | +5.6% | 149,9 k € | -63.4% | 409,7 k € | +22.6% | 334,2 k € | ||
| Debts | 236,8 k € | +24.4% | 190,3 k € | -11.2% | 214,2 k € | -58.9% | 521,3 k € | +21.7% | 428,4 k € | -59.3% | 1,1 M € | -4.0% | 1,1 M € | -51.3% | 2,3 M € | -6.7% | 2,4 M € | -31.3% | 3,5 M € | +8.3% | 3,2 M € | +7.1% | 3 M € | +0.2% | 3 M € | +42.4% | 2,1 M € | +8.0% | 2 M € | +53.1% | 1,3 M € |
| Other | |||||||||||||||||||||||||||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | -100% | 2,4 ETP | -25.0% | 3,2 ETP | -39.6% | 5,3 ETP | -10.2% | 5,9 ETP | -28.9% | 8,3 ETP | -38.5% | 13,5 ETP | +17.4% | 11,5 ETP | +0.9% | 11,4 ETP | +12.9% | 10,1 ETP | -11.4% | 11,4 ETP | +7.5% | 10,6 ETP | +1.0% | 10,5 ETP | +28.0% | 8,2 ETP | ||
Estimate
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 46 ended
Active mandates
Ended mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
2PHARMA● Active | 0886.662.746 |
2PHARMA HOLDING● Active | 0644.751.377 |
BTW-eenheid Ter Beke● Active | 0893.541.630 |
Ceres Invest● Active | 0775.683.264 |
Ceres Pharma● Active | 0641.953.324 |
Ceres Pharmaceuticals● Active | 0407.326.754 |
CONESSENCE● Active | 0819.266.552 |
Conessence Engineering● Active | 0794.812.555 |
CONESSENCE FINANCIAL RECRUITMENT● Active | 0681.915.443 |
CREDOPHAR● Active | 0849.730.193 |
DGPharma● Active | 0508.925.544 |
DRIEPUNTNUL● Active | 1021.711.292 |
HR ESSENTIALS● Active | 0721.702.467 |
KOUTERLOS● Active | 0450.036.349 |
Labophar● Active | 0643.723.177 |
MD Pharma● Active | 0667.779.672 |
PADEL FACTORY● Active | 0801.951.260 |
| 0865.651.952 | |
What’s Cooking Belgium● Active | 0884.649.304 |
What's Cooking Group● Active | 0421.364.139 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 04/06/2026 | 22/07/2025 | 31/05/2024 | 31/08/2023 | 19/05/2022 | 02/06/2021 |
| General meeting | 03/05/2026 | 30/06/2025 | 03/05/2024 | 30/06/2023 | 03/05/2022 | 03/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 03/05/2026 | 04/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/06/2025 | 22/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 03/05/2024 | 31/05/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 31/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 03/05/2022 | 19/05/2022 | Dutch | |
| Abridged model | 31/12/2020 | 03/05/2021 | 02/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/07/2020 | 26/08/2020 | Dutch | |
| Abridged model | 31/12/2018 | 30/08/2019 | 30/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 19/06/2018 | 29/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 23/06/2017 | 10/08/2017 | Dutch | |
| Full model | 31/12/2015 | 04/05/2016 | 30/08/2016 | Dutch | |
| Abridged model | 30/06/2014 | 03/11/2014 | 19/11/2014 | Dutch | |
| Abridged model | 30/06/2013 | 04/11/2013 | 06/01/2014 | Dutch | |
| Abridged model | 30/06/2012 | 03/11/2012 | 19/12/2012 | Dutch | |
| Abridged model | 30/06/2011 | 21/11/2011 | 19/12/2011 | Dutch | |
| Abridged model | 30/06/2010 | 03/11/2010 | 27/01/2011 | Dutch | |
| Abridged model | 30/06/2009 | 03/11/2009 | 27/01/2010 | Dutch | |
| Abridged model | 30/06/2008 | 03/11/2008 | 18/12/2008 | Dutch | |
| Abridged model | 30/06/2007 | 03/11/2007 | 29/01/2008 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 46 ended
Active mandates
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates27/04/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Registered office24/02/2023MAATSCHAPPELIJKE ZETEL
- Mandates05/01/2023ONTSLAGEN - BENOEMINGEN
- Mandates16/09/2020ONTSLAGEN - BENOEMINGEN
- Mandates02/07/2018MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates20/03/2018ONTSLAGEN - BENOEMINGEN
- Mandates04/07/2016ONTSLAGEN - BENOEMINGEN
- Mandates15/02/2016BENAMING - ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025213,5 k €↑
- 2024Annual accounts 2024203,2 k €↑
- 2023Annual accounts 2023194,5 k €↓
- 2022Annual accounts 2022416,9 k €↑
- 2021Annual accounts 2021162,8 k €↑
- 2019Annual accounts 2019-177 k €↓
- 2018Annual accounts 2018239,4 k €↓
- 2017Annual accounts 2017439,3 k €↑
- 2016Annual accounts 2016182,9 k €↑
- 2015Annual accounts 2015-25,3 k €↓
- 2014Annual accounts 201425,9 k €↑
- 2013Annual accounts 2013-549,5 k €↓
- 2012Annual accounts 2012-351 k €↑
- 2011Annual accounts 2011-872,7 k €↓
- 2010Annual accounts 2010345 €↑
- 2009Annual accounts 2009-390 k €
- 22/05/2001IncorporationPublic limited company